The Food and Drug Administration (FDA or Agency) is withdrawing approval of two abbreviated new drug applications (ANDAs) from Ferring Pharmaceuticals, Inc. (Ferring). Ferring notified the Agency in writing that the drug products were no longer marketed and requested that the approval of the applications be withdrawn.
Document
Ferring Pharmaceuticals, Inc.; Withdrawal of Approval of Two Abbreviated New Drug Applications
The Food and Drug Administration (FDA or Agency) is withdrawing approval of two abbreviated new drug applications (ANDAs) from Ferring Pharmaceuticals, Inc. (Ferring). Ferring n...
Legal Citation
Federal Register Citation
Use this for formal legal and research references to the published document.
83 FR 27784
Web Citation
Suggested Web Citation
Use this when citing the archival web version of the document.
“Ferring Pharmaceuticals, Inc.; Withdrawal of Approval of Two Abbreviated New Drug Applications,” thefederalregister.org (June 14, 2018), https://thefederalregister.org/documents/2018-12762/ferring-pharmaceuticals-inc-withdrawal-of-approval-of-two-abbreviated-new-drug-applications.